Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | APLT | Common Stock | Options Exercise | $7.76K | +7.39K | +1.93% | $1.05 | 390K | Sep 14, 2022 | Direct | F1 |
transaction | APLT | Common Stock | Options Exercise | $10.7K | +10.2K | +2.62% | $1.05 | 400K | Sep 14, 2022 | Direct | |
transaction | APLT | Common Stock | Options Exercise | $17.3K | +16.5K | +4.12% | $1.05 | 417K | Sep 14, 2022 | Direct | |
transaction | APLT | Common Stock | Options Exercise | $4.33K | +4.13K | +0.99% | $1.05 | 421K | Sep 14, 2022 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | APLT | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -7.39K | -100% | $0.00* | 0 | Sep 14, 2022 | Common Stock | 7.39K | $1.05 | Direct | F2 |
transaction | APLT | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -10.2K | -100% | $0.00* | 0 | Sep 14, 2022 | Common Stock | 10.2K | $1.05 | Direct | F2 |
transaction | APLT | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -16.5K | -100% | $0.00* | 0 | Sep 14, 2022 | Common Stock | 16.5K | $1.05 | Direct | F2 |
transaction | APLT | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -4.13K | -25% | $0.00 | 12.4K | Sep 14, 2022 | Common Stock | 4.13K | $1.05 | Direct | F3 |
Id | Content |
---|---|
F1 | Includes 67,435 shares previously reported as indirectly held through a family trust of which the reporting person and his spouse are trustees. In accordance with SEC guidance with respect to shares held by living trusts, such shares are now included in the shares directly owned by the reporting person. |
F2 | These Options are fully vested. |
F3 | Reflects an initial grant of 16,500 Options granted on June 3, 2022 to directors under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. One-twelfth (1/12th) of the shares subject to the Option shall vest on July 2, 2022 and each month thereafter, subject to the Reporting Person continuing to provide services through each such date. |